255 related articles for article (PubMed ID: 22151412)
41. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.
Shawcross DL; Sharifi Y; Canavan JB; Yeoman AD; Abeles RD; Taylor NJ; Auzinger G; Bernal W; Wendon JA
J Hepatol; 2011 Apr; 54(4):640-9. PubMed ID: 21163546
[TBL] [Abstract][Full Text] [Related]
42. Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study.
Wunsch E; Koziarska D; Kotarska K; Nowacki P; Milkiewicz P
Liver Int; 2013 Oct; 33(9):1332-40. PubMed ID: 23651263
[TBL] [Abstract][Full Text] [Related]
43. Minimal hepatic encephalopathy: time to recognise and treat.
Dhiman RK; Chawla YK
Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
[TBL] [Abstract][Full Text] [Related]
44. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.
Romero-Gómez M; Boza F; García-Valdecasas MS; García E; Aguilar-Reina J
Am J Gastroenterol; 2001 Sep; 96(9):2718-23. PubMed ID: 11569701
[TBL] [Abstract][Full Text] [Related]
45. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
[TBL] [Abstract][Full Text] [Related]
46. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
Sharma P; Sharma BC; Puri V; Sarin SK
Am J Gastroenterol; 2009 Apr; 104(4):885-90. PubMed ID: 19293781
[TBL] [Abstract][Full Text] [Related]
47. Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6.
Tsai CF; Chu CJ; Huang YH; Wang YP; Liu PY; Lin HC; Lee FY; Lu CL
PLoS One; 2015; 10(6):e0128437. PubMed ID: 26039496
[TBL] [Abstract][Full Text] [Related]
48. Nitric oxide, ammonia, and CRP levels in cirrhotic patients with hepatic encephalopathy: is there a connection?
Papadopoulos N; Soultati A; Goritsas C; Lazaropoulou C; Achimastos A; Adamopoulos A; Dourakis SP
J Clin Gastroenterol; 2010; 44(10):713-9. PubMed ID: 20495469
[TBL] [Abstract][Full Text] [Related]
49. Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients.
Wuensch T; Ruether DF; Zöllner C; Mueller T; Jung T; Kaffarnik M; Kassner U; Schott E; Kiefer S; Pratschke J; Stockmann M; Jara M
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):456-463. PubMed ID: 28092641
[TBL] [Abstract][Full Text] [Related]
50. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
[TBL] [Abstract][Full Text] [Related]
51. Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).
Badea MA; Drug VL; Dranga M; Gavrilescu O; Stefanescu G; Popa I; Mihai C; Cijevschi-Prelipcean C
Metab Brain Dis; 2016 Dec; 31(6):1463-1471. PubMed ID: 27461111
[TBL] [Abstract][Full Text] [Related]
52. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW
Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324
[TBL] [Abstract][Full Text] [Related]
53. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?
Pflugrad H; Bronzlik P; Raab P; Tryc AB; Goldbecker A; Barg-Hock H; Strassburg CP; Ding XQ; Lanfermann H; Weissenborn K
Liver Int; 2015 Jul; 35(7):1816-23. PubMed ID: 25546380
[TBL] [Abstract][Full Text] [Related]
54. Effect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: a note of caution.
Efrati C; Masini A; Merli M; Valeriano V; Riggio O
Am J Gastroenterol; 2000 Dec; 95(12):3574-8. PubMed ID: 11151894
[TBL] [Abstract][Full Text] [Related]
55. Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study.
Bajaj JS; Thacker LR; Heuman DM; Sterling RK; Stravitz RT; Sanyal AJ; Luketic V; Fuchs M; Gilles HC; Wade JB
Liver Transpl; 2012 Oct; 18(10):1179-87. PubMed ID: 22674517
[TBL] [Abstract][Full Text] [Related]
56. Arterial ammonia with Blood Ammonia Checker II and with indophenol reaction to assess presence of hepatic encephalopathy.
Huizenga JR; van Dam GM; Gips CH
Clin Chim Acta; 1996 Aug; 252(1):73-82. PubMed ID: 8814363
[TBL] [Abstract][Full Text] [Related]
57. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis.
Gitlin N; Lewis DC; Hinkley L
J Hepatol; 1986; 3(1):75-82. PubMed ID: 3745889
[TBL] [Abstract][Full Text] [Related]
58. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography.
Keiding S; Sørensen M; Bender D; Munk OL; Ott P; Vilstrup H
Hepatology; 2006 Jan; 43(1):42-50. PubMed ID: 16374868
[TBL] [Abstract][Full Text] [Related]
59. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
[TBL] [Abstract][Full Text] [Related]
60. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
